Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
113.48
-0.43 (-0.38%)
Jan 17, 2025, 4:00 PM EST - Market closed
Abbott Laboratories Revenue
Abbott Laboratories had revenue of $10.64B in the quarter ending September 30, 2024, with 4.85% growth. This brings the company's revenue in the last twelve months to $41.22B, up 3.15% year-over-year. In the year 2023, Abbott Laboratories had annual revenue of $40.11B, down -8.12%.
Revenue (ttm)
$41.22B
Revenue Growth
+3.15%
P/S Ratio
4.79
Revenue / Employee
$361,553
Employees
114,000
Market Cap
196.83B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 40.11B | -3.54B | -8.12% |
Dec 31, 2022 | 43.65B | 578.00M | 1.34% |
Dec 31, 2021 | 43.08B | 8.47B | 24.47% |
Dec 31, 2020 | 34.61B | 2.70B | 8.48% |
Dec 31, 2019 | 31.90B | 1.33B | 4.34% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Eli Lilly and Company | 40.86B |
ABT News
- 3 days ago - Abbott pushes toddler milks that can cause health issues: lawsuit - New York Post
- 4 days ago - The Near-Perfect Dividend Portfolio With 10 Sleep-Well-At-Night Gems - Seeking Alpha
- 12 days ago - Abbott Laboratories Q4 2024 Earnings Preview - Seeking Alpha
- 18 days ago - Abbott Hosts Conference Call for Fourth-Quarter Earnings - PRNewsWire
- 21 days ago - My New Year's Resolution For 2025: Invest $10,000 In These 6 Stocks - Seeking Alpha
- 21 days ago - Highest Quality Dividend Kings For 2025 - Seeking Alpha
- 27 days ago - DexCom, Abbott Agree to Settlement in Patent Litigation - WSJ
- 27 days ago - Abbott and DexCom settle glucose monitor patent disputes - Reuters